Role of islet β cell autophagy in the pathogenesis of diabetes

Trends in Endocrinology and Metabolism

Volumn 25, Issue 12, 2014, Pages 620-627

  Lee, Myung Shik ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Autophagy; ER stress; Islet amyloid; Obesity; cell

Indexed keywords

AMYLIN; AMYLOID PROTEIN; EXENDIN 4; LIPID; LIRAGLUTIDE; METFORMIN; RAPAMYCIN; ROSIGLITAZONE;

AUTOPHAGY; DIABETES MELLITUS; HUMAN; INFLAMMATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 84921458749     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2014.08.005     Document Type: Review

References (98)

1. Klionsky D.J., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
2. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-7416.
3. Deter R.L., de Duve C. Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes. J. Cell Biol. 1967, 33:437-449.
4. Pfeifer U. Inhibition by insulin of the formation of autophagic vacuoles in rat liver. J. Cell Biol. 1978, 78:152-167.
5. Sarbassov D.D., et al. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 2005, 17:596-603.
6. Chang I., et al. Role of calcium in pancreatic islet cell death by IFN-gamma/TNF-alpha. J. Immunol. 2004, 172:7008-7014.
7. Maechler P., Wollheim C.B. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 1999, 402:685-689.
8. Ozcan U., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461.
9. Petersen K.F., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
10. Ashrafi G., Schwarz T.L. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013, 20:31-42.
11. Bernales S., et al. ER-phagy: selective autophagy of the endoplasmic reticulum. Autophagy 2007, 3:285-287.
12. Mizushima N. The role of the Atg1/ULK1 complex in autophagy regulation. Curr. Opin. Cell Biol. 2010, 22:132-139.
13. Di Bartolomeo S., et al. The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy. J. Cell Biol. 2010, 191:155-168.
14. Matsunaga K., et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat. Cell Biol. 2009, 11:385-396.
15. Hamasaki M., et al. Autophagosomes form at ER-mitochondria contact sites. Nature 2013, 495:389-393.
16. Hamasaki M., Yoshimori T. Where do they come from? Insights from autophagosome formation. FEBS Lett. 2010, 584:1296-1301.
17. Yu L., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465:942-946.
18. Ashford T.P., Porter K.R. Cytoplasmic components in hepatic cell lysosomes. J. Cell Biol. 1962, 12:198-202.
19. Marsh B.J., et al. Regulated autophagy controls hormone content in secretory-deficient pancreatic endocrine beta-cells. Mol. Endocrinol. 2007, 21:2255-2269.
20. Orci L., et al. Insulin, not C-peptide, is present in crinophagic bodies of the pancreatic β-cell. J. Cell Biol. 1984, 98:222-228.
21. Twig G., et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008, 27:433-446.
22. Ebato C., et al. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab. 2008, 8:325-332.
23. Jung H.S., et al. Loss of autophagy diminishes pancreatic β-cell mass and function with resultant hyperglycemia. Cell Metab. 2008, 8:318-324.
24. Komatsu M., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131:1149-1163.
25. Abe H., et al. Exendin-4 improves β-cell function in autophagy-deficient β-cells. Endocrinology 2013, 154:4512-4524.
26. Chen Z-F., et al. Liraglutide prevents high glucose level induced insulinoma cells apoptosis by targeting autophagy. Chin. Med. J. (Engl.) 2013, 126:937-941.
27. Yusta B., et al. GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab. 2006, 4:391-406.
28. Noyan-Ashraf M.H., et al. A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity. Circulation 2013, 127:74-85.
29. Sharma S., et al. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. PLOS ONE 2011, 6:e25269.
30. Wauson E.M., et al. G protein-coupled receptors and the regulation of autophagy. Trends Endocrinol. Metab. 2014, 25:274-282.
31. Kaniuk N.A., et al. Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes 2007, 56:930-939.
32. Back S.H., et al. Translation attenuation through eIF2alpha phosphorylation prevents oxidative stress and maintains the differentiated state in beta cells. Cell Metab. 2009, 10:13-26.
33. Scheuner D., et al. Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. Nat. Med. 2005, 11:757-764.
34. Houck S.A., et al. Quality control autophagy degrades soluble ERAD-resistant conformers of the misfolded membrane protein GnRHR. Mol. Cell 2014, 54:166-179.
35. Quan W., et al. Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice. Diabetologia 2012, 55:392-403.
36. Merksamer P.I., et al. Real-time redox measurements during endoplasmic reticulum stress reveal interlinked protein folding functions. Cell 2008, 135:933-947.
37. 2+ depletion. J. Biol. Chem. 1993, 268:12003-12009.
38. Cunha D.A., et al. Initiation and execution of lipotoxic ER stress in pancreatic beta-cells. J. Cell Sci. 2008, 121:2308-2318.
39. Choi S.E., et al. Protective role of autophagy in palmitate-induced INS-1 beta cell death. Endocrinology 2009, 150:126-134.
40. Bachar-Wikstrom E., et al. Stimulation of autophagy improves endoplasmic reticulum stress-induced diabetes. Diabetes 2013, 62:1227-1237.
41. Bartolome A., et al. Autophagy plays a protective role in endoplasmic reticulum stress-mediated pancreatic β cell death. Autophagy 2012, 8:1757-1768.
42. Jiang Y., et al. Metformin plays a dual role in MIN6 pancreatic β cell function through AMPK-dependent autophagy. Int. J. Biochem. Cell Biol. 2014, 10:268-277.
43. Wu J., et al. Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5'-AMP-activated protein kinase modulation. Endocrine 2013, 44:87-98.
44. Han D., et al. Activation of autophagy through modulation of 5'-AMP-activated protein kinase protects pancreatic β-cells from high glucose. Biochem. J. 2010, 425:541-551.
45. Fujimoto K., et al. Autophagy regulates pancreatic beta cell death in response to Pdx1 deficiency and nutrient deprivation. J. Biol. Chem. 2009, 284:27664-27673.
46. Shen S., et al. The end of autophagic cell death?. Autophagy 2012, 8:1-3.
47. Tenemura M., et al. Rapamycin causes upregulation of autophagy and impairs islets function both in vitro and in vivo. Am. J. Transplant. 2012, 12:102-114.
48. Masini M., et al. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia 2009, 52:1083-1086.
49. Koga H., et al. Altered lipid content inhibits autophagic vesicular fusion. FASEB J. 2010, 24:3052-3065.
50. Shibata M., et al. The MAP1-LC3 conjugation system is involved in lipid droplet formation. Biochem. Biophys. Res. Commun. 2009, 382:419-423.
51. Singh R., et al. Autophagy regulates lipid metabolism. Nature 2009, 458:1131-1135.
52. Yang L., et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab. 2010, 11:467-478.
53. Las G., et al. Fatty acids suppress autophagic turnover in β-cells. J. Biol. Chem. 2011, 286:42534-42544.
54. Komiya K., et al. Free fatty acids stimulates autophagy in pancreatic β-cells via JNK pathway. Biochem. Biophys. Res. Com. 2010, 401:561-567.
55. Hosokawa N., et al. Generation of cell lines with tetracycline-regulated autophagy and a role for autophagy in controlling cell size. FEBS Lett. 2006, 580:2623-2629.
56. Mizushima N., et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell 2004, 15:1101-1111.
57. Lim Y-M., et al. Systemic autophagy insufficiency compromises adaptation to metabolic stress and facilitates progression from obesity to diabetes. Nat. Commun. 2014, (in press).
58. Yin J-J., et al. The role of autophagy in endoplasmic reticulum stress-induced pancreatic β-cell death. Autophagy 2012, 8:158-164.
59. Westermark P., et al. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 2011, 91:795-826.
60. Kahn S.E., et al. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 1999, 48:241-253.
61. Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006, 443:780-786.
62. Kim J., et al. Amyloidogenic peptide oligomer accumulation in autophagy-deficient β-cells leads to diabetes. J. Clin. Invest. 2014, 125:3311-3324.
63. Rivera J.F., et al. Autophagy defends pancreatic β-cells from human islet amyloid polypeptide-induced toxicity. J. Clin. Invest. 2014, 124:3489-3500.
64. Haataja L., et al. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr. Rev. 2008, 29:303-316.
65. Rivera J.F., et al. Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-postivie cytoplasmic inclusions. Cell Death Differ. 2011, 18:415-426.
66. Morita S., et al. Autophagy protects against human islet amyloid polypeptide-associated apoptosis. J. Diabetes Investig. 2011, 2:48-55.
67. Shigihara N., et al. Human IAPP-induced pancreatic beta-cell toxicity and its regulation by autophagy. J. Clin. Invest. 2014, 124:3634-3644.
68. Sarkar S., et al. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and α-synuclein. J. Biol. Chem. 2007, 282:5641-5652.
69. Hiddinga H.J., et al. Expression of wild-type and mutant S20G hIAPP in physiologic knock-in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance. J. Diabetes Investig. 2012, 3:138-147.
70. Costes S., et al. β-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency. Diabetes 2011, 60:227-238.
71. Costes S., et al. UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells. Autophagy 2014, 10:1004-1014.
72. Miklossy J., et al. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol. Aging 2010, 31:1503-1515.
73. Steneberg P., et al. The type 2 diabetes-associated gene ide is required for insulin secretion and suppression of α-synuclein levels in β-cells. Diabetes 2013, 62:2004-2014.
74. Strom A., et al. Impaired glucose tolerance in mice lacking cellular prion protein. Pancreas 2011, 40:229-232.
75. Janson J., et al. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 1999, 48:491-498.
76. Jayasinghe S.A., Langen R. Lipid membranes modulate the structure of islet amyloid polypeptide. Biochemistry 2005, 44:12113-12119.
77. Park K., Verchere C.B. Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. J. Biol. Chem. 2001, 276:16611-16616.
78. Feuerer M., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009, 15:930-939.
79. Hotamisligil G.S., et al. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
80. Vandanmagsar B., et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011, 15:179-188.
81. Wen H., et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011, 12:408-415.
82. Youm Y-H., et al. Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology 2012, 152:4039-4045.
83. Kuger T.A., Sansonetti P.J. NLR functions beyond pathogen recognition. Nat. Immunol. 2011, 12:121-128.
84. Masters S.L., et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat. Immunol. 2010, 11:897-904.
85. Westwell-Roper C., et al. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J. Immunol. 2011, 187:2755-2765.
86. Saitoh T., et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008, 456:264-269.
87. Kim K.H., Lee M-S. Autophagy - a key player in cellular and body metabolism. Nat. Rev. Endocrinol. 2014, 10:322-337.
88. He C., et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 2012, 481:511-515.
89. Pyo J.O., et al. Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat. Commun. 2013, 4:2300.
90. Barlow A.D., et al. Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms. Diabetes 2013, 62:2674-2682.
91. Fraenkel M., et al. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 2008, 57:945-957.
92. + T cell-induced cytotoxicity. Diabetes 2008, 57:415-423.
93. Kalender A., et al. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab. 2010, 11:390-401.
94. Kim K.H., et al. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation. Biochem. Biophys. Res. Commun. 2013, 440:76-81.
95. Madiraju A.K., et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 2014, 510:542-546.
96. Shin N-R., et al. An increase in the Akkermansia sp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014, 63:727-735.
97. Meier J.J. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 2012, 8:728-742.
98. Hoyer-Hansen M., Jaatela M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 2007, 14:1576-1582.